Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
typical criminal manipulation
the little biotech stocks refuse to go up. Its all momentum trading and they are not in favor right now. nobody does any real research on these little bio techs. there are a whole bunch trading below cash.
i have never seen such an undervalued stock as FBIO. Their stake in CKPT and MBIO is worth the total market value of fbio. If you go to their website you will see all of the other companies and subsidiaries that fbio owns or has a stake in. They own journey medical which had sales of 25 mil last year. That company alone is worth about 100 mil if they sold it.On top of that they have a potential deal for atxi which they own 40% .They also have a potential deal with caelum biosciences another subsidiary. FBIO should have a market cap of at least 400 mil not 100 mil.People just dont do their due diligence they just chase momentum.
Michael Spector, President and Chief Executive Officer of Caelum, said, “CAEL-101 appears to have a unique capability of binding to both kappa and lambda misfolded proteins. Data from the Phase 1a/1b study indicate that CAEL-101 is a well-tolerated therapy that leads to a rapid and clinically relevant organ response, particularly in the heart and kidneys. Further, CAEL-101 showed a statistically significant improvement from baseline in global longitudinal strain, an endpoint that has been correlated with survival in patients with AL amyloidosis. We are very pleased to collaborate with Alexion, a global leader in the rare disease field.”
Under the terms of the agreement, Alexion will acquire a minority equity interest in Caelum and an exclusive option to acquire the remaining equity in the company based on Phase 2 data for pre-negotiated economics. Alexion will make payments to Caelum totaling up to $60 million, including the purchase price for the equity and milestone-dependent development funding payments. The collaboration also provides for potential additional payments of up to $500 million, including the upfront and regulatory and commercial milestone payments, in the event Alexion exercises the acquisition option. The collaboration will leverage Alexion’s expertise in rare disease antibody development and commercial franchise in hematology. Alexion and Caelum will collaborate on the design of the ongoing development program for CAEL-101. Caelum will be responsible for conducting the development program through the end of Phase 2 and for manufacturing CAEL-101.
maybe the stupidest comment i have ever read
what happened today is just total market manipulation. They just wanted to take it down for no reason. No wonder volume in wall street is down people realize that the markets are controlled by buy and sell programs the quants run the markets. who wants to trade against these programs.
please stop drinking the kool aid. to be a multi dollar stock would require a market cap of 2 billion dollars. lets see if they can have a market cap of 25 million.
That is the most truthful comment i have read regarding aryc
how can a company that reports on twitter about $200,000 a week in sales have a market cap of 3mil. There is something rotten in denmark. Why doesnt this inept management address this situation. How about a letter to shareholders explaining what really is going on. People have totally lost confidence in this company and this management. Time is of the essence. I know that mgmt reads these messages so now is the time to take a stand. Please let us long suffering shareholders know what is going on regarding lawsuits, revenues and other pertinent facts that affect the company. I really dont care how many twitter followers you have and how it compares to other companies. Your stock is imploding again. It is time to address the situation ASAP.
nobody gives a damn about these tweets. why dont you release the financials. Somebody tell mgmt amateur hour is over. Who runs this joke of a company.
amazing how a company reports sales every day which probably adds up to millions of dollars a year in sales and the stock is valued at $4mil market cap. I have seen companies with these sales numbers valued easily at $20mil.market cap. This is what the street thinks of the people running this company. They are clueless and have lost all credibility and it is a shame because this company really could have been something. If a person invests in real estate they are taught the most basic principal. location location location. If you invest in a stock there is another basic principal which people overlook or tend to forget and that is management management management. This management is not shareholder friendly and have managed to destroy a company due to their incompetency. Where this stock goes from here is anyones guess but the street is certainly not betting on anything good happening. Who knows what is next another billion share dilution. Unfortunately I bought stock a few years earlier at a lot higher price before the dilution.
all these tweets mean zero until we see the current financials. This mgmt has such a bad track record that nothing they say is believable until we see filings. I never ever heard of a company posting every sale they make. How can anybody take this company seriously, and that my friends is why this stock cant break a penny. Maybe apple should tweet every time they sell an iphone.
its a shame that markets are now controlled by quants that have no idea what they are doing, they have their computerized programs and that is how the markets now work. how is it possible for the markets to be at almost 21,000 and have no volatility in the markets. there is something very wrong with this. i guess it is the markets way of saying we dont want day traders because without volatility day trading becomes close to impossible
If the company isnt ready to release its financial statements they should at least give some guidance on revenue. They tweet about all these sales well what are we talking how much are we talking. i am sure they have the numbers to make some statement meanwhile the stock just goes nowhere. As i have said before it doesnt matter what product you have for sale if management is inept as it is here your stock goes nowhere. These people are clueless in running a public company. They need to bring in somebody who has successfully run a public company. doubt it will ever happen mainly because they dont care about the shareholder.
When mgmt is this incompetent you cant expect the stock to do anything. If they would bring in outside people to run this company things might get better, but as long as the same 2 people are running this company things will stay the same. Dont forget that this stock was trading a few years ago at 1.00 before they decided to dilute the hell out of this stock. They have total disregard for the shareholder. I was in this piece of crap in 2014 and thought i had a real winner unfortunately decisions were made to destroy the shareholder. The only way i will believe things will get better is if i see it in the numbers that come out in the 10k and not some tweets.
never saw a company post sales for every item they sell whether it is a sale of $5000 or $250 just kind of sad. If they sold $7000 a day it would amount to about $2.5 mil a year. That makes the stock fairly valued. The company should only twitter sales of $20,000 or above. Maybe people will take the company more serious.
What you failed to mention is that the company totally diluted the stock.Even if the market cap goes to 100mil the stock would trade at .12 There are 800mil shares outstanding. I was in this stock a few years ago when it traded at .90 then against all common wisdom they did this massive dilution and now you have a stock trading at under a penny. This management is totally inept at running a company. I finally realize what i heard many times. Its management that makes a stock work, doesnt matter if you have the greatest product if mgmt is inept your company will go nowhere. No better example that this. I think the realistic upside is about .05
It is true the stock traded at .93 but since then mgmt totally diluted the stock, now there are 700 million shares outstanding. If you think that this is going to be a 5 dollar stock that means the market cap is 3.5 billion dollars. Keep on dreaming. I think the upside is about 15 cents which gives it a market value of 100 million. Mgmt is totally inept at running a public company. I was involved a few years ago and am still licking my wounds. sorry to burst your bubble
this could be the worst trading stock. They need to get onto a real exchange. Good news lasts about 4 hours with this stock. Totally undervalued but nobody cares.
timber
genetic testing
..
.
.
..
.
.
IRVINE, Calif., Dec. 5, 2013 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, today announced that the American College of Obstetricians and Gynecologists (ACOG) has issued new guidelines indicating that chromosomal microarray analysis (CMA) is now recommended as the first-line genetic test in pregnancies showing fetal abnormalities on an ultrasound screen.
The ACOG guidelines also indicate that microarray testing is recommended as the preferred genetic test to help identify the cause of death in stillbirths and intrauterine fetal demise when further cytogenetic analysis is desired because of its increased likelihood of obtaining results and improved detection of causative abnormalities.
CMA is a DNA-based method of prenatal genetic testing. Like the conventional prenatal genetic test known as karyotyping, CMA can identify major chromosomal defects such as Down syndrome. But CMA can also find many other genetic defects that are too small to be detected by karyotyping. Both CMA and karyotyping require testing of fetal tissue obtained with chorionic villus sampling (CVS) or amniocentesis.
"We believe this new guidance from ACOG recommending CMA as the first-line test when an ultrasound reveals one or more major fetal abnormalities is a significant milestone in the evolution of genetic testing for fetal abnormalities, but one that we had expected based on the clinical data from recently published studies," said Mark McDonough, President and CEO. "Due to the support of ACOG and its opinion leaders, we believe clinicians are now more likely to counsel patients on the availability of microarray testing and offer this option to them as a first-line test. We believe ACOG's recognition of microarray testing's increased likelihood of obtaining results and improved detection of causative abnormalities in stillbirths and intrauterine fetal demise also is an important milestone in those areas of care."
About CombiMatrix Corporation
CombiMatrix Corporation provides valuable molecular diagnostic solutions and
The company wouldn't settle if there is no money involved. What is in it for bcyp to settle for nothing. Maybe IR was told to say this.
It could just well be a fund like SAC capital liquidating stock because of redemptions